Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001301120-25-000035

Chief Scientific Officer sold 3,227 shares at $2.96 ($9,562)

  • Chief Scientific Officer acquired 3,227 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moreadith Randall · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-16 Exercise or conversion : show line 1 in the form 10b5-1 +3,227 $0.06 $194 3,227 D
2025-12-16 Sale : show line 2 in the form 10b5-1 −3,227 $2.96 $9,562 0 D
Open-market sales · 3,227 sh · avg $2.96 · $9,562

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-16 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −3,227 361,959 D
Loading xslF345X05/wk-form4_1766019414.xml…